Institutional Fund
Affinity Asset Advisors, LLC
New York, NYCIK 17731955 filings on record
Portfolio Value
$1.68B
Q1 2026
Holdings
92
Reported positions
New Buys
20
Opened this quarter
QoQ Change
+23.7%
from $1.35B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Apogee Therapeutics Inc6.5%
- Xenon Pharmaceuticals Inc5.8%
- Erasca Inc5.2%
- Insmed Inc4.7%
- Roivant Sciences Ltd4.6%
- Spyre Therapeutics Inc3.8%
- Other69.4%
Portfolio Holdings
92 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 1.28M | $108.15M | 6.5% | +50.0K | Added |
| 2 | Xenon Pharmaceuticals Inc | 1.68M | $97.40M | 5.8% | +425.0K | Added |
| 3 | Erasca Inc | 5.35M | $86.56M | 5.2% | +1.45M | Added |
| 4 | Insmed Inc | 480.0K | $78.49M | 4.7% | +30.0K | Added |
| 5 | Roivant Sciences Ltd | 2.80M | $77.56M | 4.6% | +1.10M | Added |
| 6 | Spyre Therapeutics Inc | 1.28M | $64.52M | 3.8% | −153.5K | Reduced |
| 7 | Centessa Pharmaceuticals PLC | 1.40M | $55.61M | 3.3% | +799.4K | Added |
| 8 | Praxis Precision Medicines I | 170.0K | $54.77M | 3.3% | −15.0K | Reduced |
| 9 | Anaptysbio Inc | 940.0K | $52.13M | 3.1% | +495.3K | Added |
| 10 | Alkermes PLC | 1.35M | $47.74M | 2.8% | +350.0K | Added |
82 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio